Source	Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
10383LMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	750 mg	3	$729.71	$31.60	$31.60

Source	Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
10391XMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	1000 mg	0	$845.38	$31.60	$31.60

Source	Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
10401KMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	750 mg	3	$706.93	$31.60	$31.60

Source	Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
10402LMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	1000 mg	0	$870.10	$31.60	$31.60

Source	Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
10581XMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	1000 mg	0	$845.38	$31.60	$31.60

Source	Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
10588GMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	750 mg	3	$706.93	$31.60	$31.60

Source	Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
10589HMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	1000 mg	0	$870.10	$31.60	$31.60

Source	Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
10597RMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	750 mg	3	$729.71	$31.60	$31.60

Source	General Schedule
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Medicinal Product Pack (Name, form & strength and pack size)	Max qty packs	Max qty units	No. of repeats	DPMQ	Max Safety Net	General Patient Charge
10682FMP	TRASTUZUMAB trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)	1	1	3	$1608.57	$31.60	$31.60
	Available brands
	Herceptin SC

Source	Section 100 (CT)
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Medicinal Product Pack (Name, form & strength and pack size)	Max qty packs	Max qty units	No. of repeats	DPMQ	Max Safety Net	General Patient Charge
10743KMP	TRASTUZUMAB trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)	1	1	3	$1470.22	$31.60	$31.60
	Available brands
	Herceptin SC

Source	General Schedule
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Medicinal Product Pack (Name, form & strength and pack size)	Max qty packs	Max qty units	No. of repeats	DPMQ	Max Safety Net	General Patient Charge
10798HMP	TRASTUZUMAB trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)	1	1	0	$1608.57	$31.60	$31.60
	Available brands
	Herceptin SC

Source	General Schedule
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Medicinal Product Pack (Name, form & strength and pack size)	Max qty packs	Max qty units	No. of repeats	DPMQ	Max Safety Net	General Patient Charge
10803NMP	TRASTUZUMAB trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)	1	1	3	$1608.57	$31.60	$31.60
	Available brands
	Herceptin SC

Source	Section 100 (CT)
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Medicinal Product Pack (Name, form & strength and pack size)	Max qty packs	Max qty units	No. of repeats	DPMQ	Max Safety Net	General Patient Charge
10811BMP	TRASTUZUMAB trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)	1	1	0	$1470.22	$31.60	$31.60
	Available brands
	Herceptin SC

Source	Section 100 (CT)
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Medicinal Product Pack (Name, form & strength and pack size)	Max qty packs	Max qty units	No. of repeats	DPMQ	Max Safety Net	General Patient Charge
10817HMP	TRASTUZUMAB trastuzumab 600 mg/5 mL injection, 5 mL vial (PI, CMI)	1	1	3	$1470.22	$31.60	$31.60
	Available brands
	Herceptin SC

Source	Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
4632TMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	500 mg	0	$467.00	$31.60	$31.60

Source	Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
4639EMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	250 mg	9	$328.55	$31.60	$31.60

Source	Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
4650RMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	1000 mg	0	$845.38	$31.60	$31.60

Source	Chemotherapy Items for Public Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
4703MMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	750 mg	3	$706.93	$31.60	$31.60

Source	Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
7264HMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	500 mg	0	$486.43	$31.60	$31.60

Source	Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
7265JMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	250 mg	9	$346.04	$31.60	$31.60

Source	Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
7266KMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	1000 mg	0	$870.10	$31.60	$31.60

Source	Chemotherapy Items for Private Hospital use - Explanatory Notes
Body System	ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS > ANTINEOPLASTIC AGENTS > MONOCLONAL ANTIBODIES AND ANTIBODY DRUG CONJUGATES

Note

Authority Required (STREAMLINED)

Code & Prescriber	Name, manner of administration	Max amount	No. of repeats	DPMA	Max Safety Net	General Patient Charge
7267LMP	TRASTUZUMAB Injection (PI, CMI) Available brands Herzuma (trastuzumab 440 mg injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack) Herzuma (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 150 mg injection, 1 vial) Kanjinti (trastuzumab 420 mg injection, 1 vial) Ogivri (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 150 mg injection, 1 vial) Trazimera (trastuzumab 60 mg injection, 1 vial)	750 mg	3	$729.71	$31.60	$31.60